Misoprostol is a prostaglandin analog used to reduce the risk of NSAID related ulcers, manage miscarriages, prevent post partum hemorrhage, and also for first trimester abortions. The stimulation of prostaglandin receptors in the stomach reduces gastric acid secretion, while stimulating these receptors in the uterus and cervix can increase the strength and f...
Misoprostol is indicated as a tablet to reduce the risk of NSAID induced gastric ulcers but not duodenal ulcers in high risk patients. Misoprostol is also formulated in combination with diclofenac to treat symptoms of osteoarthritis or rheumatoid arthritis in patients with a high risk of developing gastric ulcers. Misoprostol is used off label for the manage...
Fundacion Orientame, Bogotá, Colombia
Ahmed Samy, Giza, Egypt
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Montefiore Medical Center Weiler Division / Albert Einstein College of Medicine, Bronx, New York, United States
Christiana Care Health Systems, Newark, Delaware, United States
Carafem Health Center, Chevy Chase, Maryland, United States
Enas Mahmoud, Cairo, Egypt
Centro Hospitalar São João, Porto, Portugal
Ain Shams University, Cairo, Cairo Governorate, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.